Sartorius AG
XETRA: SRT.DE
Stock price
167.5 EUR
(-57.81%) 5 years
Financial Performance
5Y price score: (88)
against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index,
while a score above 100 means it outperformed the S&P 500.
10Y return: 142.5%
EUR Per
Share
Earnings per share
Free cash flow per share
Stock price
By default your notes are visible only to you.
145.4
52-week range
208.0
Your model inputs
| Required return / cost of capital |
| FCFF terminal growth rate |
Valuation
Free Cash Flow Yield
2 %
Dividend Yield TTM
0.5 %
Market cap
11,566.3
Price / Earnings TTM
74.8
Price / Book TTM
5.4
PEG TTM
0.9
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
13.2 %
(56.6) %
142.5 %
Free cash flow per share growth
(62.2) %
(21.8) %
1,418.5 %
Earnings per share growth
83.6 %
(52.3) %
21.1 %
Founded: 1,870
Employees: 13,762
Business Summary:
all figures in EUR Millions except per share data
Periods:
View:
Forecast:
Averages
based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.
Analysts
Average Revenue and Net Income forecast estimates from analysts who cover the stock.
Custom
you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.
ㅤ
Please log in / sign up view historical financials. It is free under TopFunds
Light plan.
Increase
Decrease
Total
| Required return / cost of capital |
| FCFF terminal growth rate |
| Free cash flow forecast |
| Terminal value |
| ㅤPV breakdown |
| Enterprise value / PV of FCF |
| ㅤPlus / (Less): Net Debt |
| ㅤLess: preferred stock |
| ㅤLess: minority interest |
| Market cap |
| ㅤNumber of shares |
| Price per share |
Please log in / sign up to calculate fair value based on selected inputs
Latest Earnings Call Takeaways
2025 Q4 (Feb 3, 2026)
1) Strategy & Leadership - CEO Michael Grosse expressed gratitude for the team's dedication and highlighted a smooth transition into his role. - The company focused on operational management amidst a challenging environment, achieving improved financial performance. - Sartorius aims for sustainable innovation-led growth, emphasizing investments in R&D and production capacity.
2) Financial & Segment Results - Full-year sales revenue increased by 7.6% in constant currencies, reaching slightly over EUR 3.5 billion. - Underlying EBITDA rose by 11.2% to EUR 1.052 billion, with a margin of 29.7%. - Bioprocess Solutions saw 9.5% growth in sales, driven by mid-teens growth in consumables, while Lab Products & Services remained flat at 0.2% growth. - The Americas and APAC regions both grew by 8.9%, with EMEA showing almost 6% growth.
| Metric | 2025 Results |
|---|---|
| Sales Revenue | EUR 3.5 billion |
| Underlying EBITDA | EUR 1.052 billion |
| EBITDA Margin | 29.7% |
| Bioprocess Solutions Growth | 9.5% |
| Lab Products Growth | 0.2% |
3) Problems / Headwinds - Equipment sales continued to be soft, although stabilizing in H2 2025. - The company faced headwinds from U.S. dollar weakness and tariffs, impacting reported sales growth. - The ongoing cautious investment activities from core customers contributed to a challenging market environment.
4) Operational or Product Plans - Sartorius launched several new products, including a PFAS-free filtration solution and a continuous bioprocessing platform. - The company completed expansions in Aubagne and Germany and is constructing a new site in South Korea to enhance manufacturing capabilities. - The acquisition of MATTEK is expected to contribute positively to growth, particularly in advanced 3D cell models.
5) Guidance & Outlook / Investor Angle - For 2026, Sartorius expects sales growth of 5% to 9% and an underlying EBITDA margin slightly above 30%. - The guidance reflects cautious optimism, with expectations for continued growth in Bioprocess Solutions and stabilization in Lab Products & Services. - The company anticipates that equipment sales will remain stable, with growth in consumables expected to be in the low teens, excluding China.
Bottom line: Sartorius demonstrated strong operational performance in 2025, positioning itself for sustainable growth in 2026 despite ongoing market challenges. The company’s focus on innovation and strategic investments, coupled with a solid order book, supports a positive outlook for shareholders.
Sartorius AG — Financial Overview, Stock Price, Market Cap
Sartorius AG is a company. Founded in 1870. As of April 13, 2026, the company's market capitalization is $11566324570 with a current stock price of $167.50.